Olga Ivanov on Survivorship in Breast Cancer

The resubmitted biologics license application for remestemcel-L has been issued a complete response letter.

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

The FDA has granted blinatumomab full approval for patients with minimal residual disease–positive B-cell acute lymphoblastic leukemia.

In this episode of "The Vitals," Ellen Miller, MSN, FNP-BC, talks about meeting a patient who realized she wanted to get pregnant after undergoing chemoradiation as a teenager.

A cohort study identified factors associated with late deaths in childhood cancer survivors.

Nurse researchers sought to improve the communication between the hematopoietic stem cell transplantation care team and pediatric patient caregivers.